Guy Furniss1, Bijia Shi2, Alejandro Jimenez1, Scott A Harding1, Peter D Larsen3. 1. Cardiology Department, Wellington Hospital, Wellington, New Zealand Wellington Cardiovascular Research Group, Wellington, New Zealand. 2. Wellington Cardiovascular Research Group, Wellington, New Zealand University of Otago Wellington, PO Box 7343, Wellington, New Zealand. 3. Wellington Cardiovascular Research Group, Wellington, New Zealand University of Otago Wellington, PO Box 7343, Wellington, New Zealand peter.larsen@otago.ac.nz.
Abstract
AIMS: Previous studies have reported the defibrillation testing during implantable cardioverter defibrillator (ICD) implantation is associated with elevated cardiac biomarkers and ST-segment electrocardiogram (ECG) changes suggesting that shocks during testing may cause harm. However, the effects of testing have not been isolated from the implant procedure itself, where lead deployment may cause myocardial damage. This prospective study examined high sensitivity troponin T (hs-TnT) levels and ECG changes during ICD implanting alone, ICD implantation with testing and device testing as a stand-alone procedure. METHODS AND RESULTS: We examined hs-TnT at baseline, and 6-8 h post procedure and 12 lead ECG at baseline, and 30 s, 5 min, and 10 min post right ventricle lead deployment and post defibrillation. There was no significant change in hs-TnT levels in a group of patients (n = 11) undergoing defibrillation testing alone, while hs-TnT was significantly elevated in patients undergoing implantation alone (n = 13, median increase 96%, P = 0.005) and in patients undergoing implantation and testing (n = 13, median increase 161%, P = 0.005). There was a significant correlation between the number of lead deployments and the percentage change in hs-TnT (r = -0.51, P = 0.01), but no correlation between either the number of shocks (r = 0.26, P = 0.25) or the total delivered energy (r = 0.24, P = 0.30) and percentage change in hs-TnT. CONCLUSION: Implantation of ICD leads was associated with release of troponin, but we did not observe any evidence that ICD shocks alone cause myocardial injury. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Previous studies have reported the defibrillation testing during implantable cardioverter defibrillator (ICD) implantation is associated with elevated cardiac biomarkers and ST-segment electrocardiogram (ECG) changes suggesting that shocks during testing may cause harm. However, the effects of testing have not been isolated from the implant procedure itself, where lead deployment may cause myocardial damage. This prospective study examined high sensitivity troponin T (hs-TnT) levels and ECG changes during ICD implanting alone, ICD implantation with testing and device testing as a stand-alone procedure. METHODS AND RESULTS: We examined hs-TnT at baseline, and 6-8 h post procedure and 12 lead ECG at baseline, and 30 s, 5 min, and 10 min post right ventricle lead deployment and post defibrillation. There was no significant change in hs-TnT levels in a group of patients (n = 11) undergoing defibrillation testing alone, while hs-TnT was significantly elevated in patients undergoing implantation alone (n = 13, median increase 96%, P = 0.005) and in patients undergoing implantation and testing (n = 13, median increase 161%, P = 0.005). There was a significant correlation between the number of lead deployments and the percentage change in hs-TnT (r = -0.51, P = 0.01), but no correlation between either the number of shocks (r = 0.26, P = 0.25) or the total delivered energy (r = 0.24, P = 0.30) and percentage change in hs-TnT. CONCLUSION: Implantation of ICD leads was associated with release of troponin, but we did not observe any evidence that ICD shocks alone cause myocardial injury. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Jordan Brewster; Travis Sexton; Gary Dhaliwal; Richard Charnigo; Gustavo Morales; Kevin Parrott; Yousef Darrat; John Gurley; Susan Smyth; Claude S Elayi Journal: Pacing Clin Electrophysiol Date: 2017-03-08 Impact factor: 1.976
Authors: Cian P McCarthy; Omair Yousuf; Alvaro Alonso; Elizabeth Selvin; Hugh Calkins; John W McEvoy Journal: Am J Cardiol Date: 2017-02-09 Impact factor: 2.778
Authors: Verena Semmler; Jürgen Biermann; Bernhard Haller; Clemens Jilek; Nikolaus Sarafoff; Carsten Lennerz; Hrvoje Vrazic; Bernhard Zrenner; Stefan Asbach; Christof Kolb Journal: PLoS One Date: 2015-07-24 Impact factor: 3.240
Authors: Ben McCartney; Adam Harvey; Amy Kernaghan; Sara Morais; Olibhéar McAlister; Paul Crawford; Pardis Biglarbeigi; Raymond Bond; Dewar Finlay; David McEneaney Journal: Resusc Plus Date: 2022-02-01